Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Surmodics Inc (SRDX) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 312,450
  • Shares Outstanding, K 13,050
  • Annual Sales, $ 71,370 K
  • Annual Income, $ 9,990 K
  • 36-Month Beta 0.99
  • Price/Sales 4.38
  • Price/Book 2.92

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.45 +1.28%
on 11/30/16
29.00 -18.10%
on 11/14/16
-1.10 (-4.43%)
since 11/02/16
3-Month
23.45 +1.28%
on 11/30/16
30.75 -22.76%
on 10/04/16
-5.73 (-19.44%)
since 09/02/16
52-Week
17.45 +36.10%
on 03/24/16
30.75 -22.76%
on 10/04/16
+3.15 (+15.29%)
since 12/02/15

Most Recent Stories

More News
SurModics (SRDX) Beats Q4 Earnings & Revenues Estimates

SurModics' (SRDX) fourth-quarter of fiscal 2016 adjusted earnings of 26 cents per share beat the Zacks Consensus Estimate of 9 cents.

Surmodics Reports Fourth Quarter Fiscal 2016 Results

--GAAP EPS of $0.20, Non-GAAP EPS of $0.26

Surmodics to Present at Canaccord Genuity Medical Technology and Diagnostics Forum

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that Gary Maharaj, president and chief...

Surmodics to Webcast Fourth Quarter and Fiscal Year 2016 Earnings Conference Call on November 16

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its...

Surmodics Announces Launch of Serene(R) Single-Coat (SC) Solutions Offering Unmatched Lubricity and Durability to a Broader Range of Device Applications

Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, announced the launch of a single-coat formulation of its...

39.0% Return Seen to Date on SmarTrend SurModics Call (SRDX)

SmarTrend identified an Uptrend for SurModics (NASDAQ:SRDX) on January 28th, 2016 at $20.44. In approximately 9 months, SurModics has returned 38.98% as of today's recent price of $28.40.

Uptrend Call Working As SurModics Stock Rises 43.5% (SRDX)

SmarTrend identified an Uptrend for SurModics (NASDAQ:SRDX) on January 28th, 2016 at $20.44. In approximately 9 months, SurModics has returned 43.48% as of today's recent price of $29.32.

Downgrade Alert for SurModics (SRDX)

SurModics (NASDAQ:SRDX) was downgraded from Buy to Neutral at Sidoti today. The stock closed yesterday at $29.23 on volume of 86,000 shares, above average daily volume of 56,000. In the past 52 weeks,...

SurModics Up 48.1% Since SmarTrend Uptrend Call (SRDX)

SmarTrend identified an Uptrend for SurModics (NASDAQ:SRDX) on January 28th, 2016 at $20.44. In approximately 8 months, SurModics has returned 48.08% as of today's recent price of $30.26.

43.1% Return Seen to Date on SmarTrend SurModics Call (SRDX)

SmarTrend identified an Uptrend for SurModics (NASDAQ:SRDX) on January 28th, 2016 at $20.44. In approximately 8 months, SurModics has returned 43.06% as of today's recent price of $29.24.

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More

Business Summary

SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring...

See More

Support & Resistance

2nd Resistance Point 24.28
1st Resistance Point 24.02
Last Price 23.75
1st Support Level 23.62
2nd Support Level 23.48

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.